Download PDF
Thromb Haemost 1997; 78(06): 1473-1479
DOI: 10.1055/s-0038-1665436
Rapid Communication
Schattauer GmbH Stuttgart

Thrombin and Its Precursor in Human Cerebrospinal Fluid

Irina V Smirnova
1   The Neurobiology Research Laboratory, Department of Veterans Affairs Medical Center, Kansas City, MO
2   Department of Neurology, University of Kansas Medical Center, Kansas City, KS
,
Andres Salazar
3   Department of Clinical Investigation, Walter Reed Army Medical Center, Washington, DC, USA
,
Paul M Arnold
4   Department of Surgery (Neurosurgery), University of Kansas Medical Center, Kansas City, KS
,
Sander Glatt
2   Department of Neurology, University of Kansas Medical Center, Kansas City, KS
,
Michael Handler
5   Department of Pathology and Oncology (Neuropathology), University of Kansas Medical Center, Kansas City, KS
,
Barry W Festoff
1   The Neurobiology Research Laboratory, Department of Veterans Affairs Medical Center, Kansas City, MO
2   Department of Neurology, University of Kansas Medical Center, Kansas City, KS
› Author Affiliations
Further Information

Publication History

Received 19 1996

Accepted after resubmission 18 July 1997

Publication Date:
12 July 2018 (online)

  PDF Download  Permissions and Reprints

Summary

The blood coagulation cascade proteolytic enzyme, thrombin, affects many cell types, including neurons and astrocytes, in which it prevents process outgrowth and induces significant morphological degeneration and even cell death. Since thrombin may contribute significantly to pathological conditions in the central nervous system (CNS), where it is synthesized locally, we measured the levels of thrombin and its precursor, prothrombin, in the cerebrospinal fluid (CSF) of 67 individuals from 6 groups: non-neurologic controls (NNC); spinal degenerative disease (SDD); peripheral nerve disease (PND); cerebrovascular, neuroimmune and seizure disorders and tumor (CNSD); traumatic brain injury (TBI) and neurodegenerative disorders (NDD). We employed a sensitive chromogenic assay utilizing the thrombin specific tripeptide substrate, S-2238, to evaluate CSF levels of thrombin and prothrombin. The latter estimated after its conversion to active enzyme by the snake venom prothrombinase, ecarin. No measurable active thrombin was detected in these CSF samples. However, activatable prothrombin was measured in all groups. The mean activatable prothrombin concentrations (in nM) were 7.26 ± 3.39 (NNC); 8.85 ± 3.09 (SDD); 6.78 ± 2.58 (PND); 6.33 ± 3.87 (CNSD); 5.10 ± 1.86 (TBI), and 7.80 ± 3.27 (NDD). Duncan’s multiple comparison test showed significant reduction (p <0.05) in prothrombin levels of the TBI group. Our data suggests that the prothrombin zymogen gains access to the CSF, likely-across either an intact or compromised blood-brain barrier (BBB), in increased amounts with age. Reduced levels in TBI patients may have diagnostic and/or prognostic value.

 

  • References

  • 1 Fenton JW. Regulation of thrombin generation and functions. Semin Thromb Heamost 1988; 14: 234-240
    PubMedGoogle Scholar
  • 2 Vu TK, Hung DT, Wheaton VI, Coughlin SR. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 1991; 64: 1057-1068
    CrossrefPubMedGoogle Scholar
  • 3 Pouyssegur J, L’Allemain G, Lenormand P, Pages G, Pavirani A, Rasmussen U, Van Obberghen-Schilling E, Vouret-Craviari V. Alpha-thrombin receptor and MAP kinases in the control of cell growth. Nouv Rev Française Hematol 1993; 35: 263-264
    PubMedGoogle Scholar
  • 4 Grabham P, Cunningham DD. Thrombin receptor activation stimulates astrocyte proliferation and reversal of stellation by distinct pathways: Involvement of tyrosine phosphorylation. J Neurochem 1995; 64: 583-591
    PubMedGoogle Scholar
  • 5 Gurwitz D, Cunningham DD. Thrombin modulates and reverses neuroblastoma neurite outgrowth. Proc Natl Acad Sci USA 1988; 85: 3440-3444
    CrossrefPubMedGoogle Scholar
  • 6 Suidan HS, Stone SR, Hemmings BA, Monard D. Thrombin causes neurite retraction in neuronal cells through activation of cell surface receptors. Neuron 1992; 8: 363-375
    CrossrefPubMedGoogle Scholar
  • 7 Cavanaugh KP, Gurwitz D, Cunningham DD, Bradshaw RA. Reciprocal modulation of astrocyte stellation by thrombin and protease nexin-1. J Neurochem 1990; 54: 1735-1743
    CrossrefPubMedGoogle Scholar
  • 8 Beecher KL, Andersen TT, Fenton JW, Festoff BW. Thrombin receptor peptides induce shape change in neonatal murine astrocytes in culture. J Neurosci Res 1994; 37: 108-115
    CrossrefPubMedGoogle Scholar
  • 9 Fenton JW. Thrombin. Ann NY Acad Sci 1986; 485: 05-15
    CrossrefPubMedGoogle Scholar
  • 10 Vaughan PJ, Pike CJ, Cotman CW, Cunningham DD. Thrombin receptor activation protects neurons and astrocytes from cell death produced by environmental insults. J Neurosci 1995; 15: 5389-5401
    CrossrefPubMedGoogle Scholar
  • 11 Smith-Swintosky VL, Zimmer S, Fenton JW II, Mattson MP. Protease nexin-1 and thrombin modulate neuronal Ca2+ homeostasis and sensitivity to glucose deprivation-induced injury. J Neurosci 1995; 15: 5840-5850
    CrossrefPubMedGoogle Scholar
  • 12 Akiyama H, Ikeda K, Kondo H, McGeer PL. Thrombin accumulation in brains of patients with Alzheimer’s disease. Neurosci Lett 1992; 146: 152-154
    CrossrefPubMedGoogle Scholar
  • 13 Nishino A, Suzuki M, Ohtani H, Motohashi O, Umezawa K, Nagura H, Yoshimoto T. Thrombin may contribute to the pathophysiology of central nervous system injury. J Neurotrauma 1993; 10: 167-179
    CrossrefPubMedGoogle Scholar
  • 14 Dihanich M, Kaser M, Reinhard E, Cunningham D, Monard D. Prothrombin mRNA is expressed by cells of the nervous system. Neuron 1991; 6: 575-581
    CrossrefPubMedGoogle Scholar
  • 15 Deschepper CF, Bigomia V, Berens ME, Lapointe MC. Production of thrombin and antithrombin III by brain and astroglial cell cultures. Brain Res Mol Brain Res 1991; 11: 355-358
    CrossrefPubMedGoogle Scholar
  • 16 Monard D. Tinkering with certain blood components can engender distinct functions in the nervous system. Perspect Dev Neurobiol 1993; 1: 165-168
    PubMedGoogle Scholar
  • 17 Ho GJ, Smirnova IV, Akaaboune M, Hantai D, Festoff BW. Serine proteases and their serpin inhibitors in Alzheimer’s disease. Biomed Pharmacother 1994; 48: 296-304
    CrossrefPubMedGoogle Scholar
  • 18 Smirnova IV, Ho GJ, Fenton JWI, Festoff BW. Extravascular proteolysis and the nervous system: serine protease/serpin balance. Semin Thromb Hemost 1994; 20: 426-432
    Article in Thieme ConnectPubMedGoogle Scholar
  • 19 Festoff BW, Smirnova IV, Ma JX, Citron BA. Thrombin, its receptor and protease nexin I its potent serpin in the nervous system. Semin Thromb Hemost 1996; 22: 267-271
    Article in Thieme ConnectPubMedGoogle Scholar
  • 20 Dube RK, Sahaa PK, Dube B, Katiyar BC, Rao PV. Fibrinogen, fibrinogen degradation products and fibrinolytic activity in cerebrospinal fluid in stroke. Ind J Med Res 1980; 72: 454-457
    PubMedGoogle Scholar
  • 21 Schisano G, Franco A, Nina P, Papa ML, Iannuzzi M, De Biase R, Caldora M. Monitoring of fibrin and fibrinogen degradation products (FDP) in the cerebrospinal fluid of patients with subarachnoid haemorrhage due to ruptured aneurysm. Report of 55 cases. J Neurosurg Sci 1994; 38: 77-86
    PubMedGoogle Scholar
  • 22 Suzuki M, Ogawa A, Sakurai Y, Nishino A, Venohara K, Mizoi K, Yoshimoto T. Thrombin activity in cerebrospinal fluid after subarachnoid hemorrhage. Stroke 1992; 23: 1181-1182
    CrossrefPubMedGoogle Scholar
  • 23 Lottenberg R, Christensen U, Jackson CM, Coleman PL. Assay of coagulation proteases using peptide chromogenic and fluorogenic substrates. Methods Enzymol 1981; 80: 341-361
    PubMedGoogle Scholar
  • 24 Duncan DB. Multiple range and multiple F-test. Biometrics 1955; 11: 01-42
    CrossrefPubMedGoogle Scholar
  • 25 Fenton JW, Villanueva GB, Ofosu FA, Maraganore JM. Thrombin inhibition by hirudin: how hirudin inhibits thrombin. Haemostasis 1991; (Suppl. 21) 1: 27-31
    PubMedGoogle Scholar
  • 26 Garton MJ, Keir G, Lakshmi MV, Thompson EJ. Age-related changes in cerebrospinal fluid protein concentrations. J Neurol Sci 1991; 104: 74-80
    CrossrefPubMedGoogle Scholar
  • 27 Harrington MG, Merril CR, Torrey EF. Differences in cerebrospinal fluid proteins between patients with schizophrenia and normal persons. Clin Chem 1985; 31: 722-726
    PubMedGoogle Scholar
  • 28 Matsubara E, Hirai S, Amari M, Shoji M, Yamaguchi H, Okamoto K, Ishiguro K, Harigaya Y, Wakabayashi K. Alpha 1-antichymotrypsin as a possible biochemical marker for Alzheimer-type dementia. Ann Neurol 1990; 28: 561-567
    CrossrefPubMedGoogle Scholar
  • 29 Colover J. Immunoassay of P2 protein in cerebrospinal fluid in neurological disorders. J Clin Pathol 1991; 44: 69-72
    CrossrefPubMedGoogle Scholar
  • 30 Gijbels K, Proost P, Masure S, Carton H, Billiau A, Opdenakker G. Gelatinase B is present in the cerebrospinal fluid during experimental autoimmune encephalomyelitis and cleaves myelin basic protein. J Neurosci Res 1993; 36: 432-440
    CrossrefPubMedGoogle Scholar
  • 31 Schwagerl AL, Mohan PS, Cataldo AM, Vonsattel JP, Kowall NW, Nixon RA. Elevated levels of the endosomal-lysosomal proteinase cathepsin D in cerebrospinal fluid in Alzheimer disease. J Neurochem 1995; 64: 443-446
    PubMedGoogle Scholar
  • 32 Rozniecki JJ, Hauser SL, Stein M, Lincoln R, Theoharides TC. Elevated mast cell tryptase in cerebrospinal fluid of multiple sclerosis patients. Ann Neurol 1995; 37: 63-66
    PubMedGoogle Scholar
  • 33 Akenami FO, Siren V, Koskiniemi M, Siimes MA, Teravainen H, Vaheri A. Cerebrospinal fluid activity of tissue plasminogen activator in patients with neurological diseases. J Clin Pathol 1996; 49: 577-580
    CrossrefPubMedGoogle Scholar
  • 34 Schwartz BS, Levy GA, Fair DS, Edgington TS. Murine lymphoid procoagulant activity induced by bacterial lipopolysaccharide and immune complexes is a monocyte prothrombinase. J Exp Med 1982; 155: 1464-1479
    CrossrefPubMedGoogle Scholar
  • 35 Lindahl U, Pejler G, Bogwald J, Seljelid R. A prothrombinase complex of mouse peritoneal macrophages. Arch Biochem Biophys 1989; 273: 180-188
    CrossrefPubMedGoogle Scholar
  • 36 Sekiya F, Usui H, Inoue K, Fukudome K, Morita T. Activation of prothrombin by a novel membrane-associated protease. An alternative pathway for thrombin generation independent of the coagulation cascade. J Biol Chem 1994; 269: 32441-32445
    PubMedGoogle Scholar
  • 37 Tumell AS, Brant DP, Brown GR, Finney M, Gallimore PH, Kirk CJ, Pagliuca TRV, Campbell CJ, Michell RH, Grand RJA. Regulation of neurite outgrowth from differentiated human neuroepithelial cells: A comparison of the activities of prothrombin and thrombin. Biochem J 1995; 308: 965-973
    CrossrefPubMedGoogle Scholar
  • 38 Benzakour O, Kanthou C, Lupu F, Dennehy U, Goodwin C, Scully MF, Kakkar VV, Cooper DN. Prothrombin cleavage by human vascular smooth muscle cells: A potential alternative pathway to the coagulation cascade. J Cell Biochem 1995; 59: 514-528
    CrossrefPubMedGoogle Scholar
  • 39 Festoff BW, Rao JS, Chen M. Protease nexin I thrombin- and urokinase- inhibiting serpin concentrated in normal human cerebrospinal fluid. Neurology 1992; 42: 1361-1366
    CrossrefPubMedGoogle Scholar
  • 40 Suzuki M, Motohashi O, Nishino A, Shiina V, Mizoi K, Yoshimoto T, Kameyama M, Onuma T. Diphasic increase in thrombin-antithrombin III complex in blood from the internal jugular vein following severe head injury. Thromb Haemost 1994; 71: 155-157
    PubMedGoogle Scholar
  • 41 Baker JB, Knauer DJ, Cunningham DD. Protease nexins: secreted protease inhibitors that regulate protease actions at and near the cell surface. In: Conn PM. ed The receptors. New York: Academic Press; 1986. pp 153-172
    Google Scholar
  • 42 Stone SR, Nick H, Hofsteenge J, Monard D. Glial-derived neurite-promoting factor is a slow-binding inhibitor of trypsin thrombin, and urokinase. Arch Biochem Biophys 1987; 252: 237-244
    CrossrefPubMedGoogle Scholar
  • 43 Smirnova IV, Ma JXY, Citron BA, Ratzlaff KT, Gregory EJ, Akaaboune M, Festoff BW. Neural thrombin and protease nexin kinetics after murine peripheral nerve injury. J Neurochem 1996; 67: 2188-2199
    PubMedGoogle Scholar
  • 44 Forsyth KD, Talbot V, Beckman I. Endothelial serpins – protectors of the vasculature?. Clin Exp Immunol 1994; 95: 277-282
    PubMedGoogle Scholar
  • 45 Rayford A, Rao JS, Festoff BW. Characterization of the serpin lpha 1- antichymotrypsin, in normal human cerebrospinal fluid. J Neurochem 1992; 58: 88-94
    CrossrefPubMedGoogle Scholar
  • 46 Abraham CR. The role of the acute-phase protein alpha 1-antichymotrypsin in brain dysfunction and injury. Res Immunol 1992; 143: 631-636
    CrossrefPubMedGoogle Scholar
  • 47 Cunningham DD, Pulliam L, Vaughan PJ. Protease nexin-1 and thrombin: Injury-related processes in the brain. Thromb Haemost 1993; 70: 168-171
    Article in Thieme ConnectPubMedGoogle Scholar
  • 48 Nishino A, Suzuki M, Yoshimoto T, Otani H, Nagura H. A novel aspect of thrombin in the tissue reaction following central nervous system injury. Acta Neurochir Suppl Wien 1994; 60: 86-88
    PubMedGoogle Scholar
  • 49 Lee KR, Betz AL, Keep RF, Chenevert TL, Kim S, Hoff JT. Intracerebral infusion of thrombin as a cause of brain edema. J Neurosurg 1995; 83: 1045-1050
    CrossrefPubMedGoogle Scholar
  • 50 Lee KR, Colon GP, Betz AL, Keep RF, Kim S, Hoff JT. Edema from intracerebral hemorrhage: The role of thrombin. J Neurosurg 1996; 84: 91-96
    CrossrefPubMedGoogle Scholar
  • 51 Wagner SL, Geddes JW, Cotman CW, Lau AL, Gurwitz D, Isackson PJ, Cunningham DD. Protease nexin-1, an antithrombin with neurite outgrowth activity is reduced in Alzheimer disease. Proc Natl Acad Sci USA 1989; 86: 8284-8288
    CrossrefPubMedGoogle Scholar
  • 52 Vaughan PJ, Su J, Cotman CW, Cunningham DD. Protease nexin-1, a potent thrombin inhibitor is reduced around cerebral blood vessels in Alzheimer’s disease. Brain Res 1994; 668: 160-170
    CrossrefPubMedGoogle Scholar
  • 53 Grabham PW, Monard D, Gallimore PH, Grand RJA. Modulation of human neurite outgrowth by serine proteases – a comparison of the interaction of thrombin and prothrombin with glia-derived nexin. Eur J Neurosci 1991; 3: 663-668
    CrossrefPubMedGoogle Scholar